Investigation Reveals FDA Allows Drugs Without Proven Clinical Benefit to Languish for Years on Accelerated Pathway
Process plagued by missing efficacy data and questionable evidence; Some experts argue that FDA’s standards for evidence are too low. Since the US Food and…